Renal cancer: signaling pathways and advances in targeted therapies
Aimin Jiang(First Affiliated Hospital of Xi'an Jiaotong University), Linhui Wang(Second Military Medical University), Yu Fang(Second Military Medical University), Le Qu(Nanjing General Hospital of Nanjing Military Command), Anqi Lin(Zhujiang Hospital), Ying Liu(University of Southern California), Jinxin Li(Second Military Medical University), Kun Qiao(Southern University of Science and Technology), Ziwei He(Second Military Medical University), Peng Luo(Zhujiang Hospital)
Cited by 34
Related Papers
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
|Cancer Cell|2016|1.2k
Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase
|Journal of Biological Chemistry|2004|349
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling
|Molecular Cancer|2017|257
Clinical and molecular effects on mature burn scars after treatment with a fractional CO<sub>2</sub> laser
|Lasers in Surgery and Medicine|2012|153